Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial

Multidisciplinary molecular tumor boards (MTBs) interpret next-generation sequencing reports and help oncologists determine best therapeutic options; however, there is a paucity of data regarding their clinical utility. The purpose of this study was to determine if MTB-directed therapy improves prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Rachel W., Hutchcraft, Megan L., Weiss, Heidi L., Wu, Jianrong, Wang, Chi, Liu, Jinpeng, Jayswal, Rani, Buchanan, Mikayla, Anderson, Abigail, Allison, Derek B., El Khouli, Riham H., Patel, Reema A., Villano, John L., Arnold, Susanne M., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489195/
https://www.ncbi.nlm.nih.gov/pubmed/36103643
http://dx.doi.org/10.1200/PO.21.00524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489195/
https://www.ncbi.nlm.nih.gov/pubmed/36103643
http://dx.doi.org/10.1200/PO.21.00524

Ejemplares similares